KNW: Know Labs Inc Sotuvga nisbatan narx

Know Labs Inc (KNW) brendining ramzi va logotipi

Know Labs, Inc. (KNW) proprietary Bio-RFID texnologiyalaridan foydalangan holda, glyukozani invaziv bo'lmagan usulda monitoring qilish uchun innovatsion RF datchiklarini ishlab chiqadi. Taxminiy P/S koeffitsiyenti kompaniyaning joriy bozor qiymatini aks ettiradi, bunda 5978.50 ushbu metrikaning joriy holatini tavsiflaydi. Ekologik rivojlanish vektori plastik chiqindilarni minimallashtiradi, ishlab chiqarish ob'ektlarining begubor holati va uskunalar kalibratsiyasi esa biosensorlarning barqaror ishlab chiqarilishini ta'minlaydi.

KNW (Know Labs) P/S multiplikatori tarixi 28.04.2023dan 20.05.2023gacha

Know Labs Corp (KNW) kompaniyasining tahliliy kesimlari

- bozor narxi va tahlilchilarning maqsadli narxlari:
Aksiya kotirovkalari knowlabs.co|KNW - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi haqida ma'lumot:
Bozor qiymati Know Labs Corp|KNW - Korxona qiymati
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
Bitta aksiya hisobiga xususiy kapital Know Labs|KNW - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi knowlabs.co|KNW - Kompaniyaning umumiy aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning xususiy kapitalga nisbati Know Labs, Inc.|KNW - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Know Labs Corporation|KNW - Kompaniya qarzlari|Qarzning balans kapitallashuviga nisbati Know Labs Corp|KNW - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Know Labs|Shoshilinch likvidlik knowlabs.co
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
KNW - Kompaniyaning sof foydasi|Prognoz qilingan sof foyda Know Labs, Inc.|KNW - Narx-foyda koeffitsiyenti|Forvard P/E multiplikatori Know Labs Inc|KNW - PEG multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Know Labs Corp|KNW - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bitta aksiya uchun foyda Know Labs|KNW - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi knowlabs.co|KNW - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Know Labs, Inc.
- emitentning tushumi va sotuvlari tafsilotlari:
KNW - Kompaniya daromadi|Kompaniya daromadi prognozi knowlabs.co|KNW - Kapitalizatsiyaning daromadga nisbati|Narxning kutilayotgan daromadga nisbati Know Labs Corp
Kompaniyaning fundamental tahlili:knowlabs.co KNW
Know Labs Corp original mahsuloti

Diabetlar uchun invaziv bo'lmagan glyukoza monitoringi tizimlarining ishlab chiqilishi sug'urta to'lovlari orqali Know Labs, Inc. (KNW) kompaniyasining kelajakdagi pul oqimlarini belgilaydi. Kompaniyaning o'rtacha P/S ko'rsatkichi bilan ifodalanadigan bozor kapitalizatsiyasining savdoga nisbati, joriy biznes qiymatini daromadga nisbatan o'lchaydi, bunda shishirilgan ko'paytiruvchi ko'rsatkich tarixiy tendentsiyalar bilan solishtirganda aktivlarning qiymati pasayishi xavfini bildiradi.

Know Labs, Inc. kimlar bilan raqobatlashadi

Kapitalizatsiyaning daromadga nisbati dexcom.com DXCM|P/S multiplikatori PEN (Penumbra)|Novanta Inc (NOVT) - Sotuvga nisbatan narx|Haemonetics Corp. - P/S multiplikatori|INSP (Inspire Medical Systems Inc) - Kapitalizatsiya va daromad nisbati|PRCT: P/S multiplikatori|CNMD - Narx/daromad koeffitsiyenti|PLSE (Pulse Biosciences) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati InMode Ltd (INMD)|P/S multiplikatori PMI|P/S multiplikatori Surmodics Inc. (SRDX)|Narxning daromadga nisbati Senseonics Holdings SENS|neuropace.com - Narxning daromadga nisbati|TCMD: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati SNWV (SANUWAVE Health)|OM: P/S multiplikatori|Sotuvga nisbatan narx Electromed (ELMD)|Narxning daromadga nisbati LENSAR, Inc.|RCEL - Narx/daromad multiplikatori|Kapitalizatsiyaning daromadga nisbati PROF (Profound Medical Corp.)|P/S multiplikatori bairdmed.com (BDMD)|P/S multiplikatori EDAP (EDAP TMS)|Narx/daromad koeffitsiyenti Apyx Medical Corp (APYX)|ICCM - Narxning daromadga nisbati|Narxning sotuvga nisbati LUNG|telabio.com (TELA) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati CytoSorbents Corporation|SRTS (Sensus Healthcare Corp) - P/S multiplikatori|Sotuvga nisbatan narx Zynex Corp ZYXI|Narxning daromadga nisbati electroCore, Inc. (ECOR)|vicarioussurgical.com - Kapitalizatsiya va daromad nisbati|Inspira Technologies - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati ICU (SeaStar Medical Holding Corporation)|IRIX - Narxning daromadga nisbati|INBS - P/S multiplikatori|beyondair.net (XAIR) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati PFSA|Narxning daromadga nisbati STRATA Skin Sciences Inc.|Sotuvga nisbatan narx glucotrack.com GCTK|Kapitalizatsiyaning daromadga nisbati NAOV (NanoVibronix)|Kapitalizatsiyaning daromadga nisbati Venus Concept Corporation VERO|Nuwellis, Inc. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati AEMD|ASXC - Narxning daromadga nisbati|AVGR: Narxning daromadga nisbati|BSGM: P/S multiplikatori|Cutera Inc (CUTR) - P/S multiplikatori|NARI (Inari Medical, Inc.) - P/S multiplikatori|Narxning daromadga nisbati NVRO|Narxning daromadga nisbati ReShape Lifesciences (RSLS)|Narx/daromad koeffitsiyenti Silk Road Medical, Inc.